bluuebunny/crossref_metadata_2025_split huggingface dataset:
Pregnancy outcomes in patients complicated with pre-excitation syndrome
Authors: Wang Kana , Xin Junguo , Hu Qing , Wang Xiaodong , Yu Haiyan 
Published: March 2024

Abstract
Introduction
Pregnant women with pre-excitation syndrome are more likely to develop supraventricular tachycardia (SVT) during pregnancy and delivery, leading to an increased risk of adverse events.

Method
This was a retrospective study of 309 pregnancies in 280 women (29 women had two pregnancies in this series) with pre-excitation syndrome who delivered at West China Second University Hospital from June 2011 to October 2021. All the 309 pregnant women with pre-excitation syndrome were divided into SVT and non-SVT groups to analyze the cardiac and obstetric complications.

Results
Among the included pregnant women in the past 10 years, the prevalence of pre-excitation syndrome was 0.24% (309/127725). There were 309 cases with pre-excitation syndrome in all hospitalized pregnant women. Among them, 62 (20.1%, 62/309) had a history of SVT. In the 62 cases with SVT during pregnancy, 22 (35.5%) cases had a history of SVT. Gestational diabetes mellitus was associated with SVT during pregnancy. The cesarean section rate was 88.7% in the SVT group, which was significantly higher than that in the non-SVT group (64.8%) (P < 0.001). Cases with SVT during pregnancy had more cardiac and obstetric complications. Four fetal deaths were recorded in the SVT group. Additionally, 29 women experienced two pregnancies during the study period, among whom, five received radiofrequency ablation after the first delivery and obtained better outcomes in the second pregnancy.

Conclusion
The adverse outcomes such as cardiac complications, maternal and fetal complications (PROM, prematurity, SGA, fetal distress, etc.) in pregnant women with pre-excitation syndrome were closely related to SVT, with possible risk factors including history of SVT before pregnancy, cardiac function, heart organic abnormalities, and gestational diabetes mellitus.
Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy
Authors: Sato Tomoo , Nagai Masahiro , Watanabe Osamu , Misu Tatsuro , Takenouchi Norihiro , Ohkubo Ryuichi , Ishihara Satoshi , Tsuboi Yoshio , Katsuno Masahisa , Nakagawa Masanori , Matsushita Takuya , Aso Yasuhiro , Matsuura Eiji , Tokashiki Takashi , Mukaino Akihiro , Adachi Hiroaki , Nakanishi Kaoru , Yamaguchi Yusuke , Yamaguchi Saaya , Yamano Yoshihisa 
Published: March 2024

AbstractHuman T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic neurodegenerative disease. This multicenter, randomized phase 3 study evaluated the efficacy and safety of 0.3 mg/kg intravenous mogamulizumab, a monoclonal antibody targeting-CC chemokine receptor 4, every 12 weeks in HAM/TSP patients. This study comprised a 24-week double-blind, placebo-controlled period, 24-week open-label period, and extension treatment period. The primary endpoint was the proportion of patients with a ≥ 1-grade improvement in the Osame motor disability score (OMDS). Secondary endpoints were changes in HTLV-1 proviral load, 10-m timed walk, cerebrospinal fluid (CSF) neopterin levels, and safety. The exploratory endpoint was CSF chemokine C-X-C motif ligand 10 (CXCL10) levels. Thirty-four and 33 patients were randomized to mogamulizumab and placebo arms, respectively. At the end of the double-blind period, no significant difference was found in the OMDS improvement rate or other secondary efficacy endpoints assessing motor activities. However, the mogamulizumab arm showed a significant decrease in HTLV-1 proviral load (− 59.39 ± 29.91% vs. placebo 2.32 ± 36.31%) and CSF neopterin (p < 0.001)/CXCL10 levels (p = 0.004). The baseline OMDS pattern and the 60–80% HTLV-1 proviral load reduction were sustained through the open-label and extension treatment periods. Although a higher incidence of rash (69.2%) was reported, the safety profile was similar compared with a previous phase 1/2a study. We found no significant difference in clinical benefit; however, mogamulizumab may provide long-term clinical benefit by preventing disease progression, as CSF neopterin/CXCL10 levels are associated with long-term prognosis in HAM/TSP.Clinical Trial Registration Number: NCT03191526 (registered date: 6-June-2017).
Early intensive versus escalation treatment in patients with relapsing–remitting multiple sclerosis in Austria
Authors: Guger Michael , Enzinger Christian , Leutmezer Fritz , Di Pauli Franziska , Kraus Jörg , Kalcher Stefan , Kvas Erich , Berger Thomas ,   Austrian MS Treatment Registry (AMSTR)
Published: March 2024

Abstract
Objectives
To compare the effectiveness of early intensive treatment (EIT) versus escalation treatment (ESC) in a nationwide observational cohort of almost 1000 people with relapsing–remitting multiple sclerosis (RRMS).

Materials and methods
The EIT cohort started with alemtuzumab (AZM), cladribine (CLAD), fingolimod (FTY), natalizumab (NTZ), ocrelizumab (OCR), or ozanimod (OZA); whereas, the ESC cohort was escalated from dimethylfumarate (DMF) or teriflunomide (TERI) to AZM, CLAD, FTY, NTZ, OCR, or OZA within the Austrian MS Treatment Registry. Patients had to stay on therapy for at least 3 months and up to 16 years. The EIT cohort included 743 and the ESC cohort 227 RRMS patients. We used multinomial propensity scores for inverse probability weighting in generalized linear (GLM) and Cox proportional hazards models to correct for the bias of this non-randomized registry study.

Results
Estimated mean annualized relapse rates (ARR) were 0.09 for EIT and 0.4 for ESC patients. The incidence rate ratio (IRR) in the GLM model for relapses showed a decreased relapse probability of 78% for the EIT versus ESC cohort [IRR = 0.22, 95% CI (0.16–0.30), p < 0.001]. Analyzing the time to the first relapse by Cox regression, a hazard ratio (HR) of 0.17 [95% CI (0.13–0.22), p < 0.001] revealed a decreased risk of 83% for the EIT group. Regarding sustained Expanded Disability Status Scale (EDSS) progression for 12 weeks, a HR of 0.55 [95% CI (0.40–0.76), p < 0.001] showed a decreased probability of 45% for the EIT cohort.

Conclusions
ESC treatment after DMF and TERI revealed a higher relapse and EDSS progression probability compared to EIT in Austrian RRMS patients. Therefore, an early intensive treatment should be started in patients with an active or highly active disease course.
Long-term intraocular pressure-lowering efficacy and safety of ripasudil-brimonidine fixed-dose combination for glaucoma and ocular hypertension: a multicentre, open-label, phase 3 study
Authors: Tanihara Hidenobu , Yamamoto Tetsuya , Aihara Makoto , Koizumi Noriko , Fukushima Atsuki , Kawakita Koji , Kojima Satoshi , Nakamura Toka , Suganami Hideki ,   K-232 Clinical Study Group, Tagawa Yoshitsugu , Watanabe Hiroki , Shimizu Kiyoshi , Iwasaki Miki , Matsuzaki Sakae , Ueda Hiroko , Okayama Ryoko , Matsuoka Osamu , Hashida Setsuko , Kobayashi Sachi Amaki , Kiyosawa Motohiro , Asai Yuko , Nakajima Toru , Yoshimura Yuzuru , Sakai Takao , Nomura Ryoji , Inoue Satoshi , Hayashi Ken , Watanabe Junko , Kawabata Hidehito , Muramatsu Tomoyuki , Arai Mikki , Migita Masayoshi 
Published: March 2024

Abstract
Purpose
To evaluate the long-term efficacy and safety of ripasudil-brimonidine fixed-dose combination (RBFC), a new intraocular pressure (IOP)-lowering medication for glaucoma and ocular hypertension (OHT).

Methods
This prospective, multicentre (23 sites in Japan), open-label study enrolled patients with primary open-angle glaucoma (POAG), OHT or exfoliative glaucoma and assigned them to one of four combination therapy cohorts, based on previous treatment(s) received: prostaglandin (PG) analogue (Cohort 1); PG analogue and beta-adrenoceptor blocker (β-blocker) (Cohort 2); PG analogue, β-blocker and carbonic anhydrase inhibitor (Cohort 3); or other/no treatment (Cohort 4). After a ≥ 4-week screening period, eligible patients received twice-daily RBFC for 52 weeks in addition to the treatments they were already receiving. Efficacy was assessed by change in IOP from baseline through week 52. Adverse events and adverse drug reactions (ADRs) were monitored throughout.

Results
In total, 179 patients from Cohort 1 (n = 48), Cohort 2 (n = 44), Cohort 3 (n = 41) and Cohort 4 (n = 46) entered the RBFC treatment period. For all cohorts, mean IOP was significantly reduced at 11:00 (2 h after instillation of RBFC) through week 52 with the changes from baseline at week 52 of − 2.7 to − 4.1 mmHg across cohorts; all p < 0.001. Common ADRs were conjunctival hyperaemia (58%), allergic conjunctivitis (18%) and blepharitis (17%), most of which were mild in severity.

Conclusion
These data demonstrated the long-term efficacy and safety of RBFC, both alone and in combination with other anti-glaucoma agents. RBFC may offer a new treatment option for the long-term management of glaucoma and OHT.

Trial registration
Japan Registry of Clinical Trials Identifier: jRCT2080225063.

Date of registration
17 February 2020.
MOTS-c regulates pancreatic alpha and beta cell functions in vitro
Authors: Bień Jakub , Pruszyńska-Oszmałek Ewa , Kołodziejski Paweł , Leciejewska Natalia , Szczepankiewicz Dawid , Sassek Maciej 
Published: March 2024

AbstractThe aim of this study is to determine the influence of the mitochondrial open-reading-frame of the twelve S rRNA-c (MOTS-c) peptide on pancreatic cell physiology. Moreover, in this study, we examined the changes in MOTS-c secretion and expression under different conditions. Our experiments were conducted using laboratory cell line cultures, specifically the INS-1E and αTC-1 cell lines, which represent β and α pancreatic cells, respectively. As the pancreas is an endocrine organ, we also tested its hormone regulation capabilities. Furthermore, we assessed the secretion of MOTS-c after incubating the cells with glucose and free fatty acids. Additionally, we examined key cell culture parameters such as cell viability, proliferation, and apoptosis. The results obtained from this study show that MOTS-c has a significant impact on the physiology of pancreatic cells. Specifically, it lowers insulin secretion and expression in INS-1E cells and enhances glucagon secretion and expression in αTC-1 cells. Furthermore, MOTS-c affects cell viability and apoptosis. Interestingly, insulin and glucagon affect the MOTS-c secretion as well as glucose and free fatty acids. These experiments clearly show that MOTS-c is an important regulator of pancreatic metabolism, and there are numerous properties of MOTS-c yet to be discovered.
Reliability and validity of the MX3 portable sweat sodium analyser during exercise in warm conditions
Authors: Brown Harry A. , Clark Brad , Périard Julien D. 
Published: March 2024

Abstract
Purpose
Accurately measuring sweat sodium concentration ([Na+]) in the field is advantageous for coaches, scientists, and dieticians looking to tailor hydration strategies. The MX3 hydration testing system is a new portable analyser that uses pre-calibrated biosensors to measure sweat [Na+]. This study aimed to assess the validity and reliability of the MX3 hydration testing system.

Methods
Thirty-one (11 females) recreationally active participants completed one experimental trial. During this trial, participants exercised at a self-selected pace for 45 min in a warm environment (31.5 ± 0.8 °C, 63.2 ± 1.3% relative humidity). Sweat samples were collected from three measurement sites using absorbent patches. The samples were then analysed for sweat [Na+] using both the MX3 hydration testing system and the Horiba LAQUAtwin-NA-11. The reliability of the MX3 hydration testing system was determined following two measurements of the same sweat sample.

Results
The mean difference between measurements was 0.1 mmoL·L−1 (95% limits of agreement (LoA): − 9.2, 9.4). The analyser demonstrated a coefficient of variation (CV) of 5.6% and the standard error of measurement was 3.3 mmoL·L−1. When compared to the Horiba LAQUAtwin-NA-11, there was a mean difference of − 1.7 mmoL·L−1 (95% LoA: − 0.25$${\overline{\text{X}}}$$

X
¯

, 0.25$${\overline{\text{X}}}$$

X
¯

) and the CV was 9.8%.

Conclusion
The MX3 hydration testing system demonstrated very good single-trial reliability, moderate agreement and a very good CV relative to the Horiba LAQUAtwin-Na-11. To further validate its performance, the MX3 hydration testing system should be compared with analytical techniques known for superior reliability and validity.
Educational programmes for paediatric healthcare professionals in patient- and family-centred care. A scoping review
Authors: Jeppesen Elisabeth , Schmidt Anne Aarslev , Skjødt Camilla Kriegbaum , Hybschmann Jane , Gjærde Line Klingen , Thestrup Jakob , Hansson Helena , Sørensen Jette Led 
Published: March 2024

AbstractTo identify and describe educational programmes in patient- and family-centred care for paediatric healthcare professionals. This scoping review was conducted and reported according to the JBI Manual for Evidence Synthesis and the PRISMA guideline. The databases searched included MEDLINE (PubMed), PsycINFO, CINAHL, Scopus, Cochrane, and Embase. Inclusion criteria were experimental, observational and qualitative studies about educational programmes on patient- and family-centred care for paediatric healthcare professionals. Exclusion criteria were reviews and non-peer-reviewed literature. Two reviewers independently screened and extracted the data using Covidence. Of the 13922 records identified, 49 articles met the inclusion criteria. There was a large variety of educational programmes, half of which were interdisciplinary, that mainly targeted nurses and doctors. The median number of participants was 51 (range 7 to 1411). The predominant target population was children with chronic disabilities and neonatal intensive care units, and only one programme specifically targeted adolescents. The median duration was one day (range 5 min to 3.5 years). Development of competencies was the most common objective. We identified 12 different educational content areas. Content mainly focused on communication and relational competencies, including partnership, which involved shared decision-making, mutual agenda setting, and negotiation of a plan. Many kinds of educational strategies were found but experiential learning through simulation and roleplay was used most. Conclusion: A large variety of educational programmes in paediatric patient- and family-centred care exist. Educational content mainly focused on communication and relational competencies. Experiential learning including roleplay and simulation was the most used educational strategy.

What is Known:• Delivery of patient- and family-centred care improves parental satisfaction of care but requires clinicians have a certain attitude towards involving the child and parents in a healthcare partnership as well as advanced triadic communication skills. Little is known about how this attitude, and more broadly, patient- and family-centred care, can be facilitated through education and training.

What is New:• This scoping review found a wide array of programmes.. Workshops with simulation or roleplay was the most frequent educational strategy. The programmes, which typically targeted nurses and doctors, chiefly focused on basic and advanced communication and relational competencies, including partnership, which involved shared decision-making and negotiation of plans.
Estimation of solar cell parameters through utilization of adaptive sine–cosine particle swarm optimization algorithm
Authors: Issa Mohamed , Helmi Ahmed M. , Ghetas Mohamed 
Published: March 2024

AbstractDue to the growing demand for clean and sustainable energy sources, there has been an increasing interest in solar cells and photovoltaic panels. Nevertheless, determining the right design parameters to achieve the most efficient energy output that aligns with the energy system's needs can be quite challenging. This complexity arises from the intricate models and the inherent inaccuracies in the available information. To tackle this challenge, this paper introduces the adaptive sine–cosine particle swarm optimization algorithm (ASCA-PSO) as a method for estimating the parameters of solar cells and photovoltaic modules. The ASCA-PSO approach combines the strengths of the SCA and PSO algorithms in a two-tier process. In this process, SCA search agents explore the search space, while the PSO search agents leverage the outcomes derived from SCA exploration. This study evaluates the effectiveness of ASCA-PSO in accurately estimating the parameters of single- and double-diode models using data from two commercial solar cells. The findings are compared with those of cutting-edge methods. It is demonstrated that ASCA-PSO can identify global solutions for multifaceted and intricate objective functions. Furthermore, it proves to be a viable option for designing solar cells even in the presence of noise.
Depression, anxiety, and health-related quality of life in normal weight, overweight and obese individuals with diabetes: a representative study in Germany
Authors: Herhaus Benedict , Kruse Johannes , Hinz Andreas , Brähler Elmar , Petrowski Katja 
Published: March 2024

Abstract
Objective
Diabetes in the course of lifetime is related to a higher risk for mental disorders. The present study addresses the comparison of individuals with diabetes and non-diabetic individuals in depressive symptoms, generalized anxiety symptoms, and health-related quality of life. Furthermore, mediator effect of BMI and health-related quality of life (HRQOL) on the association between diabetes, depression, and generalized anxiety was analyzed.

Methods
In this cross-sectional study, the three questionnaires PHQ-9, GAD-7, EQ-5D-5L were measured in a representative sample of the German population (N = 2386). In addition, the presence of diabetes and BMI were assessed via self-report.

Results
There were higher values in depressive and anxiety symptoms as well as lower score in HRQOL in individuals with diabetes compared to non-diabetic individuals. Obese individuals with diabetes showed the highest rates in depressive symptoms and generalized anxiety as well as lowest score in HRQOL. With regard to the mediator analyses, association between diabetes, depressive symptoms, and anxiety symptoms is partially mediated by the BMI and fully mediated by the HRQOL.

Conclusions
In conclusion, individuals with diabetes have an increased risk in the development of depressive and anxiety symptoms as well as lower health-related quality of life. Future research and strategies in the public health policies among individuals with diabetes should take into account that the association between diabetes, depression, and anxiety is mediated by BMI and HRQOL.
Effect of sodium hypochlorite gel on bacteria associated with periodontal disease
Authors: Irani Delia , Jungbauer Gert , Sculean Anton , Eick Sigrun 
Published: March 2024

Abstract
Objectives
An adjunct in non-surgical periodontal therapy might be sodium hypochlorite (NaOCl)–based agents. The purpose of the present in vitro study was to get deeper knowledge on the influence of different parameters as time after mixing, pH, and chemical composition of an amino acid 0.475% NaOCl (AA-NaOCl) gel consisting of two components on its anti-biofilm activity.

Materials and methods
Six-species biofilms were cultured for 5 days, before AA-NaOCl gel was applied. In the different series, the influence of the time after mixing of the two components before application, of the concentration of NaOCl in the gel mixture, of the pH of the gel mixture, and of an exchange of the amino acid component by hyaluronic acid (HA), was analyzed.

Results
Mixing time point experiments showed that the AA-NaOCl gel is capable of statistically significantly reducing colony-forming unit (cfu) counts up to 30 min after mixing, but only up to 20 min after mixing the reduction was more than 2 log10 cfu. The pH experiments indicate that a reduced pH results in a reduced activity of the NaOCl formulation. NaOCl concentrations in the formulation in the range from 0.475 to 0.2% provide adequate activity on biofilms. A HA/NaOCl gel was equally active against the biofilm as the AA-NaOCl gel.

Conclusion
Mixing of the components should be made in a timeframe of 20 min before applications. An optimization of the composition of the NaOCl formulation might be possible and should be a topic in further in vitro studies.

Clinical relevance
The AA-NaOCl gel formulation can be mixed up to 20 min before application. Further, the study indicates that the composition of the NaOCl gel formulation can be optimized.
Cognitive flexibility in urban yellow mongooses, Cynictis penicillata
Authors: Müller Mijke , Pillay Neville 
Published: March 2024

Abstract
Cognitive flexibility enables animals to alter their behaviour and respond appropriately to environmental changes. Such flexibility is important in urban settings where environmental changes occur rapidly and continually. We studied whether free-living, urban-dwelling yellow mongooses, Cynictis penicillata, in South Africa, are cognitively flexible in reversal learning and attention task experiments (n = 10). Reversal learning was conducted using two puzzle boxes that were distinct visually and spatially, each containing a preferred or non-preferred food type. Once mongooses learned which box contained the preferred food type, the food types were reversed. The mongooses successfully unlearned their previously learned response in favour of learning a new response, possibly through a win-stay, lose-shift strategy. Attention task experiments were conducted using one puzzle box surrounded by zero, one, two or three objects, introducing various levels of distraction while solving the task. The mongooses were distracted by two and three distractions but were able to solve the task despite the distractions by splitting their attention between the puzzle box task and remaining vigilant. However, those exposed to human residents more often were more vigilant. We provide the first evidence of cognitive flexibility in urban yellow mongooses, which enables them to modify their behaviour to urban environments.
Do domestic budgerigars perceive predation risk?
Authors: Wang Chang , Zhao Xueqi , Tao Baodan , Peng Jiaqi , Wang Haitao , Yu Jiangping , Jin Longru 
Published: March 2024

Abstract
Predation risk may affect the foraging behavior of birds. However, there has been little research on the ability of domestic birds to perceive predation risk and thus adjust their feeding behavior. In this study, we tested whether domestic budgerigars (Melopsittacus undulatus) perceived predation risk after the presentation of specimens and sounds of sparrowhawks (Accipiter nisus), domestic cats (Felis catus), and humans, and whether this in turn influenced their feeding behavior. When exposed to visual or acoustic stimuli, budgerigars showed significantly longer latency to feed under sparrowhawk, domestic cat, and human treatments than with controls. Budgerigars responded more strongly to acoustic stimuli than visual stimuli, and they showed the longest latency to feed and the least number of feeding times in response to sparrowhawk calls. Moreover, budgerigars showed shorter latency to feed and greater numbers of feeding times in response to human voices than to sparrowhawk or domestic cat calls. Our results suggest that domestic budgerigars may identify predation risk through visual or acoustic signals and adjust their feeding behavior accordingly.